Literature DB >> 10873046

The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin.

M R Hemmila1, D S Foley, V P Castle, R B Hirschl.   

Abstract

BACKGROUND: A recent article by Law et al concluded that patients with idiopathic thrombocytopenic purpura (ITP) who have a poor response to intravenous immune globulin (IgG) are unlikely to have a good or excellent response to surgical splenectomy.
METHODS: The authors studied retrospectively 23 pediatric patients age 11.7 +/- 1.0 years with ITP who had been treated with IgG before undergoing splenectomy. As in the aforementioned article, the responses to the 2 treatments were classified on the basis of the platelet count as poor (<50,000/mm3), good (50,000 to 150,000/mm3), or excellent (>150,000/mm3). For patients who received multiple IgG treatments, both initial and final treatment responses were analyzed.
RESULTS: Sixteen patients had an excellent or good initial response to IgG. Of these 16 patients, 14 had an excellent or good response to splenectomy. Among the 7 patients who had a poor response to IgG there were 3 who had an excellent or good response to splenectomy (43%), and 4 patients who had a poor response to splenectomy. A good or excellent response to initial treatment with IgG was associated with a significant probability of a good or excellent response to splenectomy (P = .045).
CONCLUSIONS: A good or excellent response to IgG may be predictive of a favorable response to splenectomy. However, a poor response to IgG does not preclude a satisfactory response to splenectomy in pediatric patients with ITP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873046     DOI: 10.1053/jpsu.2000.6938

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  A cost-effectiveness study of intravenous immunoglobulin in childhood idiopathic thrombocytopenia purpura patients with life-threatening bleeding.

Authors:  Rosarin Sruamsiri; Piyameth Dilokthornsakul; Chayanin Pratoomsoot; Nathorn Chaiyakunapruk
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

2.  Laparoscopic splenectomy for immune thrombocytopenia (ITP) patients with platelet counts lower than 1 × 109/L.

Authors:  Zhong Wu; Jin Zhou; Prasoon Pankaj; Bing Peng
Journal:  Int J Hematol       Date:  2011-11-05       Impact factor: 2.490

3.  Contemporary pediatric splenectomy: continuing controversies.

Authors:  James H Wood; David A Partrick; Taru Hays; Angela Sauaia; Frederick M Karrer; Moritz M Ziegler
Journal:  Pediatr Surg Int       Date:  2011-05-28       Impact factor: 1.827

4.  Indium-111 OXINE scintigram in children with cITP: clinical usefulness for indicating splenectomy.

Authors:  So-Ichi Suenobu; Kensuke Akiyoshi; Seigo Korematsu; Masahisa Takuma; Hiromu Mori; Tatsuro Izumi
Journal:  Int J Hematol       Date:  2008-01-29       Impact factor: 2.490

5.  Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.

Authors:  Sandra Regina Loggetto; Josefina Aparecida Pellegrini Braga; Mônica Pinheiro de Almeida Veríssimo; Wanderley Marques Bernardo; Leticia Medeiros; Andrea Thives de Carvalho Hoepers
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.